6 insiders reported 19 Form 4 transactions for Bionano Genomics, Inc. (BNGO) over the past 18 months (most recent 2026-08-21). Recent activity: Luderer Albert (Interim Chief Executive) Buy 4,000 shares, OLDAKOWSKI MARK (CHIEF OPERATING OFFICER) Sell 27 shares, Chaubey Alka (CHIEF MEDICAL OFFICER) Sell 24 shares, Dixon Jonathan V. (GENERAL COUNSEL) Sell 24 shares, Adamchak Mark (Principal Accounting Officer) Sell 7 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Luderer Albert | Interim Chief Executive | Buy | 4,000 | $4,860 |
| 2026-06-03 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 27 | $35 |
| 2026-06-03 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 24 | $31 |
| 2026-06-03 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 24 | $31 |
| 2026-06-03 | Adamchak Mark | Principal Accounting Officer | Sell | 7 | $9 |
| 2026-02-18 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 20 | $22 |
| 2026-02-18 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 6 | $7 |
| 2026-02-18 | Holmlin R. Erik | PRESIDENT AND CEO | Sell | 51 | $56 |
| 2026-02-18 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 18 | $20 |
| 2026-02-18 | Adamchak Mark | Principal Accounting Officer | Sell | 3 | $3 |
| 2025-09-12 | Chaubey Alka | Chief Medical Officer | Sell | 51 | $207 |
| 2025-09-12 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 59 | $240 |
| 2025-09-12 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 59 | $240 |
| 2025-06-03 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 27 | $100 |
| 2025-06-03 | Holmlin R. Erik | President and CEO | Sell | 75 | $277 |
| 2025-06-03 | Chaubey Alka | Chief Medical Officer | Sell | 24 | $89 |
| 2025-06-03 | Dixon Jonathan V. | General Counsel | Sell | 25 | $92 |
| 2025-06-03 | Adamchak Mark | Principal Accounting Officer | Sell | 7 | $26 |
| 2025-03-18 | Holmlin R. Erik | President and CEO | Sell | 198 | $687 |
Source: SEC Form 4 filings · as of 2026-08-21